CENTAUR

INDEPENDANT // PRODUCT DRIVEN DEVELOPMENT

INVESTOR RELATIONS

Bootstrapping development

In the past 16 years InteSpring managed to fund all development by itself, through either realizing big assignments/projects or by obtaining innovation grants. Now all shares are kept by the founders: Boudewijn Wisse, Rogier Barents and partly still InteSpring Holding as well as two of the most important employees: Trebsijg van de Wijdeven and Frank Baas.

partners

Working with the finest partners to create excellent technology is at the core of InteSpring’s philosophy. We have experience in both the National and European level of research.

Our partners include

the main value drivers

InteSpring currently has two products in development that represent the built up in valuable IP: Centaur and Hermes.

// Centaur

LOAD CARRYING LEG EXOSKELETON

// Hermes

ANKLE ORTHOSIS FOR PES EQUINES

Get involved with a fast growing and eye-catching market!

Invest
First
Last
Interested field

cash // knowledge

investments

428K

Exobuddy NTPI: Proof of principle

910K

Exobuddy NTPII: Lab testing

1.4M

Exobuddy NTPIII: Field prototype

The Dutch Ministry of Defence and InteSpring both invested over 2.7 million euro in the development of the Exobuddy exoskeleton. All Intellectual property is owned by InteSpring. The Dutch MOD has the right of 5% royalty fee up to a maximum of €1.79 million euros. 

412K

STW: Stiffness as needed

175K

IMDI: Precision Orthotics

1.4

The Hermes project uses negative stiffness in orthoses. Negative stiffness mechanisms are at the core of the technology of InteSpring. Although the generated IP in this project is shared between partners, InteSpring solely owns the software to calculate this negative stiffness.